Institution scientifique

Centre of Excellence for Long-acting Therapeutics

Liverpool, GB, facility

35Publications signalées

432Citations signalées

12Thèmes principaux

Les principaux domaines

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchHIV/AIDS drug development and treatmentNanoparticles: synthesis and applicationsHIV Research and TreatmentSARS-CoV-2 detection and testingPregnancy and Medication ImpactPharmaceutical studies and practicesPharmacological Receptor Mechanisms and EffectsTuberculosis Research and EpidemiologyHIV/AIDS Research and InterventionsHepatitis C virus research

L’évolution annuelle

2021 3

2022 7

2024 5

2025 10

2026 10

Les publications récentes

Accès ouvert 2026 article OpenAlex

Long‐Acting Therapeutics in Pediatric Health: Bridging Innovation and Access

Prajith Venkatasubramanian, Moherndran Archary, Daniel B. Hawcutt, Rachel Daley et autres

gb, Afrique du Sud, us (code pays fourni par la source)

0 citations Clinical Pharmacology & Therapeutics

Accès ouvert 2026 preprint OpenAlex

Dose optimisation of favipiravir against RNA viruses using physiologically-based pharmacokinetic modelling

William HJ Wood, Henry Pertinez, Tim Rowland, Andrew Owen et autres

gb (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)

Accès ouvert 2026 preprint OpenAlex

Renal Outcomes and Dosage Considerations Associated with Bisphosphonate Use: A Systematic Review of Randomized Clinical Trials

Prajith Venkatasubramanian, RESHMA RAJU, Pratheeksha Sojan Biatris, Sam Johnson Udaya Chander

gb, us, ae, in (code pays fourni par la source)

0 citations Research Square

Accès ouvert 2026 article OpenAlex

A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection

Saye Khoo, Richard FitzGerald, Christopher J Edwards, Shazaad Ahmad et autres

gb, de (code pays fourni par la source)

0 citations Journal of Antimicrobial Chemotherapy

Accès ouvert 2026 article OpenAlex

A White Paper on Advancing Long‐Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation

Moherndran Archary, Robert Bies, Osei Boateng, Rachel Daley et autres

Afrique du Sud, us, gb, Rwanda, jp, Kenya, th (code pays fourni par la source)

1 citation Clinical Pharmacology & Therapeutics

Accès ouvert 2026 preprint OpenAlex

Modelling the tail-phase pharmacokinetics of long-acting cabotegravir and rilpivirine from early pregnancy to postpartum at steady state

Shakir Atoyebi, Catriona Waitt, Adeniyi Olagunju

gb, Ouganda (code pays fourni par la source)

0 citations medRxiv

Accès ouvert 2026 article OpenAlex

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID ‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

Tim Rowland, Richard FitzGerald, Elizabeth Challenger, Laura Dickinson et autres

gb, de (code pays fourni par la source)

4 citations Clinical Pharmacology & Therapeutics

Accès ouvert 2026 article OpenAlex

Accelerating Generic Long‐Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to Access

Usman Arshad, Lobna Gaayeb, Henry Pertinez, Rajith K. R. Rajoli et autres

gb, ch, us, in, nl, dk, Zimbabwe, Afrique du Sud (code pays fourni par la source)

3 citations Clinical Pharmacology & Therapeutics

Accès ouvert 2026 article OpenAlex

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley et autres

us, au, gb, Ouganda (code pays fourni par la source)

7 citations Clinical Pharmacology & Therapeutics

Accès ouvert 2026 article OpenAlex

PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing

Shakir Atoyebi, Prajith Venkatasubramanian, Abdulafeez Akinloye, Oluwasegun Eniayewu et autres

gb, au, Nigéria, us (code pays fourni par la source)

2 citations Clinical Pharmacology & Therapeutics

Accès ouvert 2025 article OpenAlex

Pharmacokinetics of nitazoxanide in plasma separation cards from patients with SARS‐CoV‐2: AGILE CST‐3a/b

Beth Thompson, Laura Else, Alieu Amara, Helen Reynolds et autres

gb, Afrique du Sud (code pays fourni par la source)

0 citations British Journal of Clinical Pharmacology

Accès ouvert 2025 article OpenAlex

Can low‐cost oral alternatives be used in place of oral Lenacapavir when initiating long‐acting lenacapavir PrEP in low‐ and middle‐income countries

Henry Pertinez, Rajith K. R. Rajoli, Charles Flexner, Andrew Owen

gb, us (code pays fourni par la source)

1 citation British Journal of Clinical Pharmacology

Site officiel Identifiant ROR

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.